Printer Friendly

ISL INTRODUCES NEW LASER SYSTEM FOR REFRACTIVE SURGERY

 SAN DIEGO, Jan. 25 /PRNewswire/ -- Intelligent Surgical Lasers Inc. (NASDAQ: ISLS), which designs and manufactures advanced laser systems for a broad range of ophthalmic disorders, announced today the introduction of a new laser system called The Eye Laser(TM), specifically designed for refractive surgery, including the correction of nearsightedness, farsightedness and astigmatism. The Eye Laser corrects these disorders by making precise incisions or ablations within the cornea, an area only a half millimeter in thickness. Successful refractive surgery using The Eye Laser can eliminate the need for glasses or corrective lenses, according to Heinz Gisel, chairman and chief executive officer.
 "The Eye Laser is the only non-excimer laser system designed for performing all types of refractive surgeries, as well as other surgeries within the eye," Gisel said. "The Eye Laser combines a low energy laser and a unique delivery system to enable doctors to make precise incisions within the cornea or eye. The accuracy, effectiveness and ease-of-use of the system combine to allow doctors to move these procedures from an expensive operating room to a less expensive outpatient environment."
 ISL's patented picosecond laser technology, consisting of a short pulse width, low energy laser, is extremely precise and causes less trauma to surrounding tissue, reducing recovery periods. The novel delivery system combines an operating microscope and a computer- controlled tracking device that enables The Eye Laser to make the precise determinations needed to deliver laser energy to specific points within the cornea or eye. ISL has filed for patents covering The Eye Laser and this novel approach for correcting refractive disorders.
 The Eye Laser is already backordered, with requests from opthalmic surgeons around the world. ISL will begin shipping the system at the end of February, according to Gisel.
 "This system can correct myopia (nearsightedness), which is caused by an excessive curvature of the cornea, by ablating or vaporizing' tissue within the cornea, thereby reducing the curvature," Gisel said. "This ablation technique can be used in a different way to increase the curvature of the eye to correct hyperopia (farsightedness), eliminate the twisting of the eye responsible for astigmatism and remove corneal scars. The Eye Laser can also make incisions within the eye to treat ophthalmic disorders such as cataracts, glaucoma and vitreous bands."
 According to research by Arthur D. Little, the number of potential annual procedures for refractive surgery in the United States alone is currently estimated to be 2 million to 3 million, with a market opportunity estimated at $2 billion to $4.5 billion by the late 1990s.
 "We listened to the needs of ophthalmic surgeons in the U.S. and worldwide and designed The Eye Laser to fully meet these needs," Gisel added. "It uses an operating microscope which is the preferred instrument for performing such delicate surgery. It is highly accurate, enabling doctors to make small, precise incisions and ablations. And by using a low energy laser, the area around the incisions or ablations is not traumatized, permitting faster recovery with less adverse side effects. As a result the surgery can be performed on an outpatient basis."
 The Eye Laser is the only non-excimer laser which can be used to correct for all types of refractive disorders. Excimer lasers have only proved useful in treating mild myopia. Higher myopia, hyperopia and astigmatism are currently treated by radial keratotomy (RK), performed manually by a surgeon using a diamond-edged knife.
 ISL expects to apply for an Investigational Device Exemption from the Food and Drug Administration by the end of first quarter 1993. ISL's Model 2001, which uses the same low energy laser system as The Eye Laser, was designed for therapeutic surgeries and has received FDA approval for use in posterior capsulotomies. Under IDEs, ISL is continuing to conduct clinical studies of the Model 2001 for iridotomy, cataract liquefaction, laser vitreolysis and other new applications.
 Intelligent Surgical Lasers Inc. (ISL) is a development stage company which designs and manufactures innovative, technologically advanced laser systems for the treatment of a broad range of ophthalmic disorders. Many of these disorders are difficult or impossible to treat with current lasers or traditional medical instruments. Founded in 1987, ISL completed a public offering in September 1992.
 -0- 1/25/93
 /CONTACT: Heinz Gisel, chairman and CEO of ISL, 619-552-6700; or Linda Seaton of Keatinge/Seaton Communications, 619-625-2100, for ISL/
 (ISLS)


CO: Intelligent Surgical Lasers Inc. ST: California IN: MTC SU: PDT

KJ-JB -- SD002 -- 8302 01/25/93 09:15 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 25, 1993
Words:738
Previous Article:ARMSTRONG WORLD INDUSTRIES ISSUES PERSONNEL ANNOUNCEMENT
Next Article:MICRONICS COMPUTERS REPORTS FIRST QUARTER FINANCIAL RESULTS
Topics:


Related Articles
INTELLIGENT SURGICAL LASERS REPORTS POSITIVE PHASE I CLINICAL DATA FOR USE OF MODEL 2001 EYE LASER SYSTEM FOR LASER VITREOLYSIS
e/ -- Intelligent Surgical Lasers, Inc. (NASDAQ: ISLS) announced today promising results from clinical studies conducted at the University of...
ISL SHIPS TWO EYE LASER SYSTEMS FOR TREATMENT OF MYOPIA AND HYPEROPIA TO ITALY
PHOENIX LASER SYSTEMS FILES U.S. PATENT FOR OPHTHALMIC WORKSTATION
NEWVISION ANNOUNCES JOHN D. HUNKELER, M.D. JOINS BOARD OF DIRECTORS
NEWVISION TECHNOLOGY, INC. ANNOUNCES THE APPOINTMENT OF MYRON YANOFF, M.D. TO ITS ADVISORY BOARD
NEWVISION TECHNOLOGY TO MOVE FORWARD WITH U.S. PLANS ON FDA PANEL'S POSITIVE RECOMMENDATION TO APPROVE EXCIMER LASER SYSTEMS IN THE U.S.
NEWVISION TECHNOLOGY, INC. ANNOUNCES DEVELOPMENT PLANS FOR FIFTEEN EXCIMER LASER MARKETS IN THE UNITED STATES
SIGHT RESOURCE BEGINS TREATING PATIENTS AT ITS CHICAGO AND PHILADELPHIA LASER VISION CORRECTION CLINICS
New opportunities for OOs in laser sector says eye surgery Top Gun.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters